A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Amy Boileau, PhD, RD, to speak on the revolutionary science behind TRU NIAGEN to Asia-Pacific nutraceutical industry IRVINE, Calif., Sept. 06, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way...
IRVINE, Calif., Aug. 30, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and consumer product TRU NIAGEN®, today announced it will be...
Second Quarter 2018 Net Revenues Increased by 85% to $7.8 Million IRVINE, Calif., Aug. 09, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and...
TRU NIAGEN® expands presence in Asia-Pacific region with entry into New Zealand IRVINE, Calif., Aug. 08, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship...
Global partnership commits to significant growth of TRU NIAGEN® including launch in Turkey IRVINE, Calif., Aug. 07, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its...
IRVINE, Calif., Aug. 02, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and consumer product TRU NIAGEN®, will hold a conference call on...
Findings from Aarhus University Hospital and the University of Copenhagen Suggest Further Studies on NIAGEN® Should Focus on Therapeutic Potential for Liver Health IRVINE, Calif., July 11, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based,...
Participation at two mid-July events will target healthcare practitioners IRVINE, Calif., July 09, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it will feature...
IRVINE, Calif., June 25, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and consumer product TRU NIAGEN®, announced today it was added as...
IRVINE, Calif., June 04, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it has appointed Lisa Bratkovich as Chief Marketing Officer, effective today. Bratkovich...